Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate‐to‐severe atopic dermatitis: Analyses of TREATgermany registry data
暂无分享,去创建一个
K. Schäkel | E. Haufe | A. Heratizadeh | T. Biedermann | M. Worm | M. Sticherling | A. Wollenberg | E. Weisshaar | S. Weidinger | B. Homey | I. Effendy | T. Werfel | D. Siegels | Luise Heinrich | S. Abraham | A. Kleinheinz | F. Wiemers | I. Fell | C. Handrick | A. Asmussen | T. Birkner | R. von Kiedrowski | B. Schwarz | I. Harder | Jochen Schmitt | M. Augustin | Konstantin Ertner | Thomas Schaefer | S. Quist | Magnus Bell | Sun-Hei Hong-Weldemann | Jens-Joachim Brücher | M. Bell | Ralph von Kiedrowski
[1] K. Schäkel,et al. Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany , 2023, Acta dermato-venereologica.
[2] K. Schäkel,et al. Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany. , 2022, The British journal of dermatology.
[3] C. Flohr,et al. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] M. Metz,et al. Characterization of the effects on pruritus by novel treatments for atopic dermatitis , 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[5] K. Schäkel,et al. Atopic dermatitis and depressive symptoms. Results of the German national AD Registry TREATgermany , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] P. Ihle,et al. Epidemiologie und Therapie von erwachsenen Patienten mit atopischer Dermatitis , 2021, Der Hautarzt.
[7] F. Legat. Itch in Atopic Dermatitis – What Is New? , 2021, Frontiers in Medicine.
[8] Shuying Zhou,et al. Biological Therapies for Atopic Dermatitis: A Systematic Review , 2021, Dermatology.
[9] L. Bianchi,et al. Quality of Life and Psychological Impact in Patients with Atopic Dermatitis , 2021, Journal of clinical medicine.
[10] T. Agner,et al. Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study , 2021, The Journal of dermatological treatment.
[11] P. Schmid‐Grendelmeier,et al. Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis , 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[12] C. Flohr,et al. Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis , 2020, Allergy.
[13] M. Worm,et al. Modern therapies in atopic dermatitis: biologics and small molecule drugs , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[14] B. Poblador-Plou,et al. Prevalence and Comorbidity of Atopic Dermatitis in Children: A Large-Scale Population Study Based on Real-World Data , 2020, Journal of clinical medicine.
[15] S. Marron,et al. Psychosocial Impact of Atopic Dermatitis in Adults: A Qualitative Study. , 2020, Actas dermo-sifiliograficas.
[16] C. Flohr,et al. Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis , 2020, JAMA dermatology.
[17] R. Treudler,et al. Atopische Dermatitis und psychosoziale Komorbidität , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[18] K. Schäkel,et al. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.
[19] G. de Carlo,et al. Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.
[20] H. van Os-Medendorp,et al. Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment. , 2019, Acta dermato-venereologica.
[21] J. Silverberg. Comorbidities and the impact of atopic dermatitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[22] J. C. Jaworski,et al. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders , 2018, American Journal of Clinical Dermatology.
[23] R. Dellavalle,et al. Systemic treatments for eczema: a network meta-analysis. , 2018, The Cochrane database of systematic reviews.
[24] J. Schmitt,et al. Verminderte berufliche Leistungsfähigkeit und Lebensqualität bei Patienten mit moderater bis schwerer Neurodermitis , 2018, Der Hautarzt.
[25] L. Skov,et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta‐analysis , 2018, Journal of the American Academy of Dermatology.
[26] H. Williams,et al. Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient‐Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative , 2018, The British journal of dermatology.
[27] T. Bieber,et al. Atopic dermatitis , 2018, Nature Reviews Disease Primers.
[28] J. Silverberg. Associations between atopic dermatitis and other disorders , 2018, F1000Research.
[29] A. Linneberg,et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide , 2018, Allergy.
[30] T. Friedli,et al. Workability for persons with chronic diseases. A systematic review of validity and utility of assessments in German language / Valide und praktikable deutschsprachige Assessments zur Erfassung der Arbeitsfähigkeit bei Menschen mit chronischen Erkrankungen – eine systematische Review , 2018 .
[31] J. Silverberg,et al. Relationship between EASI and SCORAD severity assessments for atopic dermatitis. , 2017, The Journal of allergy and clinical immunology.
[32] J. Silverberg,et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis , 2017, The British journal of dermatology.
[33] H. Williams,et al. Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement , 2017, The British journal of dermatology.
[34] M. Gooderham,et al. Atopic Dermatitis, Depression, and Suicidality , 2017, Journal of cutaneous medicine and surgery.
[35] H. Williams,et al. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) , 2016, The British journal of dermatology.
[36] P. Schmid‐Grendelmeier,et al. S2k guideline on diagnosis and treatment of atopic dermatitis — short version , 2016, Allergo Journal International.
[37] H. Williams,et al. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards. , 2016, Journal of the American Academy of Dermatology.
[38] P. Schmid‐Grendelmeier,et al. S2k‐Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion , 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[39] Masutaka Furue,et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. , 2014, The Journal of allergy and clinical immunology.
[40] J. Ravenscroft,et al. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods , 2013, The British journal of dermatology.
[41] Jochen Schmitt,et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. , 2013, The Journal of allergy and clinical immunology.
[42] J. Schmitt,et al. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference , 2012, Allergy.
[43] Ulrike Held,et al. Validation of the fatigue severity scale in a Swiss cohort. , 2008, Sleep.
[44] Adrian Pfeffer. Einsatz bei Erschöpfung , 2008, physiopraxis.
[45] B. Thombs,et al. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. , 2008, Arthritis and rheumatism.
[46] A Wolkerstorfer,et al. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three‐item severity score , 2007, The British journal of dermatology.
[47] R. Pukrop,et al. Messbarkeit von Fatigue bei multipler Sklerose mithilfe standardisierter Methoden im deutschsprachigen Raum , 2006 .
[48] H. Williams,et al. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. , 2004, Archives of dermatology.
[49] E. Berndt,et al. The Clinical and Occupational Correlates of Work Productivity Loss Among Employed Patients With Depression , 2004, Journal of occupational and environmental medicine.
[50] A. Finlay,et al. 10 years experience of the Dermatology Life Quality Index (DLQI). , 2004, The journal of investigative dermatology. Symposium proceedings.
[51] M. Graeber,et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.
[52] K. Bungay,et al. The Work Limitations Questionnaire , 2001, Medical care.
[53] R. Hay,et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. , 1994, The British journal of dermatology.
[54] D. Strachan,et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis II. Observer variation of clinical diagnosis and signs of atopic dermatitis , 1994, The British journal of dermatology.
[55] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.
[56] L. Radloff. The CES-D Scale , 1977 .
[57] H. Williams,et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. , 2015, The Journal of investigative dermatology.
[58] J. Ring,et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. , 1997, Dermatology.
[59] Julia Brasch,et al. Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .